Sort by 'comments'
Making Infertility Treatments Affordable – Insurance Policies Related to Benefits
Soaring costs of infertility treatments and preservation burn holes in the pockets of patients already dealing with the emotional upheavals of it. Insurance coverage for infertility treatment is scarce and confusing, and is important to thoroughly understand the covered benefits…
ASH 2020 Updates: CAR T Cell Therapies in Multiple Myeloma
We kickstart the new year with a discussion on CAR T cells in myeloma treatment with a focus on the CT053, a CAR T-cell therapy targeting the BCMA protein and granted orphan drug status by the U.S. Food and Drug…
UltraCAR-T Therapy – Scope & Possibilities in Multiple Myeloma Management
Ongoing clinical trials are investigating the safety and efficacy of a new type of CAR T (Chimeric antigen receptor T-cells) therapy called UltraCAR-T therapy for myeloid malignancies. Unlike current CAR T cells, which utilize viruses to attach the CAR to…
CLR 131 – A New Approach in Multiple Myeloma Treatment
CLR 131 is a targeted small-molecule that is being developed for the treatment of myeloma and lymphoma, as well as pediatric and head & neck cancers by Cellectar Biosciences. It works by delivering a radioactive, toxic compound directly to tumor…
COVID-19 Vaccines – A Practical Dilemma for Pregnant & Breastfeeding Women & Those Trying to Conceive
Covid19 vaccines roll out began in mid December 2020, with the Moderna and Pfizer-BioNTech vaccines as the first widely available shots. However these vaccines use the mRNA technology for which there is virtually no data - and will likely not…